Concordantly, when serum C-peptide, HOMA-IR, and HOMA-β were categorized into quartiles (Q1-Q4), an increasing trend in the prevalence of MASLD among T2DM patients was observed with higher quartiles of these parameters ( Figure 3(D-G) ).
← all excerpts
Glycemic variability in type 2 diabetic patients with metabolic dysfunction-associated steatotic liver disease: a case-control study.
1
—
—